Spotlight: Fostering a Culture of Innovation to Drive Growth

Develop an Innovative Culture As companies look to generate new growth, many are concerned that their culture may be inhibiting them from achieving their goals. While many people believe a stronger culture that supports innovation will lead to growth, most lack clarity about what the true impact improving culture has on innovation and what types [...]

September 27th, 2017|

Charles River 23rd Annual Biotechnology-Derived Therapeutics Perspectives on Nonclinical Development Symposium

The Charles River 23rd Annual Biotechnology-Derived Therapeutics Perspectives on Nonclinical Development symposium will be held September 11-13, 2017 at Cape Rey Resort, Carlsbad, CA. This three-day symposium with five sessions has a jam-packed agenda with case study presentations from industry leaders from Bluebird, Janssen, Pfizer and Amgen in the nonclinical development of biotherapeutics. Don’t miss out on [...]

July 24th, 2017|

Advancing Rare Disease Drug Discovery: Navigating the Path to an IND

Symposium Overview: Therapies to treat rare and undiagnosed diseases are in high demand in a favorable regulatory environment. Thus, it is critically important to optimize the discovery and development of such therapies by creating – and following – the most efficient path to an investigational new drug (IND) filing. How do we do just that? [...]

April 5th, 2017|

Spotlight: Every Challenge. Every Day. Every Voice.

Behind every patient stands thousands of scientists and researchers working together to develop life-saving treatments. So what happens when a patient meets the people that helped save her life? Watch this 8-minute documentary as Ginger Tam, a lung-cancer patient, meets the researchers who worked on her cancer treatment.    

March 1st, 2017|

Spotlight: Charles River Laboratories Acquires Agilux Laboratories, Inc.

Charles River has announced the acquisition of Agilux Laboratories, Inc., a Worcester, Massachusetts-based contract research organization (CRO) providing a suite of integrated discovery small- and large-molecule bioanalytical services, DMPK (drug metabolism and pharmacokinetics) and pharmacology services. Agilux has built an enviable reputation for flexibility and speed, offering in vivo PK (pharmacokinetics), in vitro ADME (absorption [...]

October 21st, 2016|

Spotlight: Q&A with Ian Chan, CEO & Founder, Abpro

About Abpro Abpro is an integrated life science company focused on industrial biochemistry. Through its DiversImmune™ platform, Abpro leverages synthetic biology and immunology to create novel biomolecules for use in research, diagnostics, animal health and therapeutics. Abpro’s platform has been validated by major pharmaceutical, biotechnology and academic labs around the world. What was your inspiration [...]

September 6th, 2016|

Cell Therapy Manufacturing Q&A – The Big3Bio Interview with Barbara Nelsen

Nelsen Biomedical is a life sciences consulting firm specializing in strategic development for companies with innovative technologies, involved in emerging industries, and focused on expanding markets. Founded in 2011 by Barbara Nelsen, Ph.D., Nelsen Biomedical harnesses the energy, leadership and entrepreneurship of to Minneapolis, Boston and Chicago life sciences communities to drive strategic growth for [...]

April 25th, 2016|

Innovation Spotlight: RaNA Therapeutics with Ron Renaud, CEO

Intro from Danny Levine/RARECast: "RaNA Therapeutics is pursuing treatments for rare diseases, such as spinal muscular atrophy and Friedreich’s Ataxia, with a new therapeutic approach that targets a previously unexplored druggable space. We spoke to Ron Renaud, CEO of RaNA, about his company’s effort to selectively upgregulate genes as a way to treat [...]

April 18th, 2016|

Spotlight: Charles River Massachusetts to Open

Charles River Massachusetts will open in January 2016. This 450,000 square foot facility increases capacity for PK services, non-GLP toxicology, GLP toxicology and small molecule bioanalysis, with plans to add services each year. Conveniently located just outside of Boston in Shrewsbury, the facility provides Cambridge-area clients direct access to their studies. From website: "As a [...]

December 1st, 2015|